Value of miR200b and its combination with other biochemical markers in the diagnosis of epithelial ovarian cancer
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This study found that miR200b, when combined with CA125, shows promise for diagnosing epithelial ovarian cancer (EOC) in Egyptian patients. This combination may also predict disease-free survival.
Area Of Science
- Biomarker discovery
- Molecular diagnostics
- Oncology
Background
- Epithelial ovarian cancer (EOC) diagnosis relies on biomarkers, but improved accuracy is needed.
- MicroRNAs (miRNAs) are emerging as potential diagnostic and prognostic indicators in various cancers.
- miR200b has been investigated for its role in cancer progression and metastasis.
Purpose Of The Study
- To assess the diagnostic performance of miR200b in Egyptian patients with EOC.
- To evaluate the combined diagnostic and prognostic value of miR200b with established biomarkers (CA125, HE4, CRP).
Main Methods
- Quantitative real-time PCR was used to measure cell-free miR200b expression in 30 EOC patients, 19 benign ovarian disease patients, and 14 healthy controls.
- Serum levels of CA125, HE4, and CRP were also measured in all groups.
- The diagnostic accuracy of individual biomarkers and their combinations with miR200b was analyzed.
Main Results
- miR200b was significantly overexpressed in EOC patients compared to controls (1.88-fold cutoff, 63.3% sensitivity, 71% specificity).
- CA125 demonstrated high sensitivity (96.7%) and specificity (75.9%).
- Combining miR200b with CA125 yielded the best diagnostic performance compared to other combinations.
Conclusions
- The combination of miR200b and CA125 shows potential as a reliable tool for the initial diagnosis of EOC.
- This biomarker panel may also serve as a predictor of event-free survival in EOC patients.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.